Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2008

01-12-2008

Age-related effects of regular physical activity on hemostatic factors in men

Authors: Jun Sugawara, Koichiro Hayashi, Sumiko Kurachi, Taku Tanaka, Takashi Yokoi, Kotoku Kurachi

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2008

Login to get access

Abstract

Background Age-related changes in blood coagulation and fibrinolytic factors are associated with an increase in risk of thrombotic events. The purpose of this study was to assess the effects of age, regular aerobic exercise and detraining on blood coagulation and fibrinolytic factors in men. Methods Initially, 41 sedentary and 42 physically active men (20–64 years) were analyzed for plasma levels of coagulation and fibrinolytic factors. Twelve sedentary men were then subjected to 16-week aerobic exercise training and subsequent 2-week detraining. Their blood samples taken at rest were assayed for activity levels of prothrombin, coagulation factor (F) V, VII, VIII, IX, X, XI and XIII, antithrombin III, protein C and plasminogen, and for antigen levels of fibrinogen, prothrombin fragment 1 + 2 (F1 + 2), FIX, protein C, tissue-type plasminogen activator (tPA), plasminogen activator inhibitor 1 (PAI-1) and tPA/PAI-1 complex. Results Plasma levels of most coagulation factors, particularly for fibrinogen and FIX antigens as well as FXIII activity significantly increased with aging in sedentary men, while that tendency disappeared in physically active men. By the exercise training, plasma antigen and/or activity levels of most blood coagulation factors except for prothrombin and FIX decreased. These training-effects, however, disappeared after detraining, and in some cases even rebounded to higher levels than those of pre-training. Plasma antigen levels of tPA, PAI-1 and tPA/PAI-1 complex decreased with the training and remained low even after detraining. Conclusion Regular aerobic exercises give complex effects on expression of hemostatic factors, overall favoring the hemostatic balance to less thrombotic, partly cancelling out the age effects.
Literature
1.
go back to reference Abbate R, Prisco D, Rostagno C, Boddi M, Gensini GF (1993) Age-related changes in the hemostatic system. Int J Clin Lab Res 23:1–3PubMedCrossRef Abbate R, Prisco D, Rostagno C, Boddi M, Gensini GF (1993) Age-related changes in the hemostatic system. Int J Clin Lab Res 23:1–3PubMedCrossRef
2.
go back to reference DeSouza CA, Jones PP, Seals DR (1998) Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women. Arterioscler Thromb Vasc Biol 18:362–368PubMed DeSouza CA, Jones PP, Seals DR (1998) Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women. Arterioscler Thromb Vasc Biol 18:362–368PubMed
3.
go back to reference van den Burg PJ, Hospers JE, Mosterd WL, Bouma BN, Huisveld IA (2000) Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Physiol 88:1558–1564PubMed van den Burg PJ, Hospers JE, Mosterd WL, Bouma BN, Huisveld IA (2000) Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Physiol 88:1558–1564PubMed
4.
go back to reference Kurachi K, Kurachi S (2005) Molecular mechanisms of age-related regulation of genes. J Thromb Haemost 3:909–914PubMedCrossRef Kurachi K, Kurachi S (2005) Molecular mechanisms of age-related regulation of genes. J Thromb Haemost 3:909–914PubMedCrossRef
5.
go back to reference Kannel WB, Wolf PA, Castelli WP, D’Agostino RB (1987) Fibrinogen and risk of cardiovascular disease. The Framingham Study. Jama 258:1183–1186PubMedCrossRef Kannel WB, Wolf PA, Castelli WP, D’Agostino RB (1987) Fibrinogen and risk of cardiovascular disease. The Framingham Study. Jama 258:1183–1186PubMedCrossRef
6.
go back to reference Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Jama 279:1477–1482PubMedCrossRef Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Jama 279:1477–1482PubMedCrossRef
7.
go back to reference Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC (1998) Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly study. Thromb Haemost 79:129–133PubMed Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC (1998) Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly study. Thromb Haemost 79:129–133PubMed
8.
go back to reference Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105:1785–1790PubMedCrossRef Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105:1785–1790PubMedCrossRef
9.
go back to reference Smith DT, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA (2003) Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J Physiol 546:289–298PubMedCrossRef Smith DT, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA (2003) Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J Physiol 546:289–298PubMedCrossRef
10.
go back to reference Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB (1991) Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692–1697PubMed Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB (1991) Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692–1697PubMed
11.
go back to reference Ghiu IA, Ferrell RE, Kulaputana O, Phares DA, Hagberg JM (2004) Selected genetic polymorphisms and plasma coagulation factor VII changes with exercise training. J Appl Physiol 96:985–990PubMedCrossRef Ghiu IA, Ferrell RE, Kulaputana O, Phares DA, Hagberg JM (2004) Selected genetic polymorphisms and plasma coagulation factor VII changes with exercise training. J Appl Physiol 96:985–990PubMedCrossRef
12.
go back to reference Adachi S (1996) Practical coagulation factor assays. Med Technol 24:629–633 Adachi S (1996) Practical coagulation factor assays. Med Technol 24:629–633
13.
go back to reference Ranby M, Nguyen G, Scarabin PY, Samama M (1989) Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thromb Haemost 61:409–414PubMed Ranby M, Nguyen G, Scarabin PY, Samama M (1989) Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thromb Haemost 61:409–414PubMed
14.
go back to reference Fickenscher K, Aab A, Stuber W (1991) A photometric assay for blood coagulation factor XIII. Thromb Haemost 65:535–540PubMed Fickenscher K, Aab A, Stuber W (1991) A photometric assay for blood coagulation factor XIII. Thromb Haemost 65:535–540PubMed
15.
go back to reference Friberger P, Knos M, Gustavsson S, Aurell L, Claeson G (1978) Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 7:138–145PubMed Friberger P, Knos M, Gustavsson S, Aurell L, Claeson G (1978) Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 7:138–145PubMed
16.
go back to reference Okajima K (1995) [Antithrombin III (AT III)]. Nippon Rinsho 53(Su Pt 2):43–47PubMed Okajima K (1995) [Antithrombin III (AT III)]. Nippon Rinsho 53(Su Pt 2):43–47PubMed
17.
go back to reference Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y (1993) Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy. J Cardiol 23:335–341PubMed Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y (1993) Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy. J Cardiol 23:335–341PubMed
18.
go back to reference Tanaka H, Clevenger CM, Jones PP, Seals DR, DeSouza CA (1998) Influence of body fatness on the coronary risk profile of physically active postmenopausal women. Metabolism 47:1112–1120PubMedCrossRef Tanaka H, Clevenger CM, Jones PP, Seals DR, DeSouza CA (1998) Influence of body fatness on the coronary risk profile of physically active postmenopausal women. Metabolism 47:1112–1120PubMedCrossRef
19.
go back to reference Miwa K, Nakagawa K, Yoshida N, Taguchi Y, Inoue H (2000) Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. J Am Coll Cardiol 35:1200–1205PubMedCrossRef Miwa K, Nakagawa K, Yoshida N, Taguchi Y, Inoue H (2000) Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. J Am Coll Cardiol 35:1200–1205PubMedCrossRef
20.
go back to reference Tanaka H, Monahan KD, Seals DR (2001) Age-predicted maximal heart rate revisited. J Am Coll Cardiol 37:153–156PubMedCrossRef Tanaka H, Monahan KD, Seals DR (2001) Age-predicted maximal heart rate revisited. J Am Coll Cardiol 37:153–156PubMedCrossRef
21.
go back to reference Hayashi K, Sugawara J, Komine H, Maeda S, Yokoi T (2005) Effects of aerobic exercise training on stiffness of central and peripheral arteries in middle-aged sedentary men. Jpn J Physiol 55:235–239PubMedCrossRef Hayashi K, Sugawara J, Komine H, Maeda S, Yokoi T (2005) Effects of aerobic exercise training on stiffness of central and peripheral arteries in middle-aged sedentary men. Jpn J Physiol 55:235–239PubMedCrossRef
22.
go back to reference Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, Castelli WP (1996) Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. Jama 276:544–548PubMedCrossRef Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, Castelli WP (1996) Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. Jama 276:544–548PubMedCrossRef
23.
Metadata
Title
Age-related effects of regular physical activity on hemostatic factors in men
Authors
Jun Sugawara
Koichiro Hayashi
Sumiko Kurachi
Taku Tanaka
Takashi Yokoi
Kotoku Kurachi
Publication date
01-12-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0092-y

Other articles of this Issue 3/2008

Journal of Thrombosis and Thrombolysis 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.